Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Herpesviruses are a large family of double-stranded DNA viruses (family: Herpesviridae) that infect a wide range of animal species, including humans. They are highly adapted pathogens capable of establishing lifelong latent infections with periodic reactivation. Eight herpesviruses commonly infect humans: HSV-1, HSV-2, VZV, EBV, CMV, HHV-6A/B, HHV-7, and KSHV/HHV-8. Each is associated with distinct clinical syndromes. After primary infection, often asymptomatic, herpesviruses enter sensory nerves and migrate to sensory ganglia within the central nervous system, where they establish latency as episomal DNA with minimal gene expression. Reactivation can occur due to physical or psychological stressors, leading the virus back along nerves to cause recurrent disease at peripheral sites.
Inhibition of viral DNA polymerase
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Herpesviridae (HHV).